EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$202M
This Quarter Return
-0.03%
1 Year Return
+18.55%
3 Year Return
+74.74%
5 Year Return
+137.36%
10 Year Return
+339.12%
AUM
$203M
AUM Growth
+$203M
(-3.7%)
Cap. Flow
-$1.77M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
145
New
1
Increased
36
Reduced
90
Closed
10
Top Buys
| 1 |
Tractor Supply
TSCO
|
$1.57M |
| 2 |
Lam Research
LRCX
|
$1.39M |
| 3 |
Goldman Sachs
GS
|
$793K |
| 4 |
Snap-on
SNA
|
$281K |
| 5 |
Autodesk
ADSK
|
$275K |
Top Sells
| 1 |
Fiserv
FI
|
$408K |
| 2 |
Medtronic
MDT
|
$298K |
| 3 |
Nike
NKE
|
$279K |
| 4 |
Booking.com
BKNG
|
$273K |
| 5 |
Novo Nordisk
NVO
|
$270K |
Sector Composition
| 1 | Technology | 23.9% |
| 2 | Industrials | 14.91% |
| 3 | Healthcare | 13.82% |
| 4 | Consumer Discretionary | 12.88% |
| 5 | Consumer Staples | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Graco
GGG
$14.1B
| $269K | 0.13% |
3,190
| – | – |
|
127
United Parcel Service
UPS
$74.1B
| $257K | 0.13% |
2,035
-1,427
| -41% | -$180K |
|
128
Toll Brothers
TOL
$13.4B
| $256K | 0.13% |
+2,034
| New | +$256K |
|
129
Quest Diagnostics
DGX
$20.3B
| $251K | 0.12% |
1,663
| – | – |
|
130
AT&T
T
$209B
| $250K | 0.12% |
10,975
+155
| +1% | +$3.53K |
|
131
Shell
SHEL
$215B
| $246K | 0.12% |
3,919
-120
| -3% | -$7.53K |
|
132
Lincoln National
LNC
$8.14B
| $233K | 0.11% |
7,360
-130
| -2% | -$4.12K |
|
133
Prudential Financial
PRU
$38.6B
| $225K | 0.11% |
1,896
-4
| -0.2% | -$475 |
|
134
Duke Energy
DUK
$95.3B
| $207K | 0.1% |
1,924
| – | – |
|
135
Viatris
VTRS
$12.3B
| $184K | 0.09% |
14,755
| – | – |
|
136
Amcor
AMCR
$19.9B
| – | – |
-11,111
| Closed | -$126K |
|
137
Charles River Laboratories
CRL
$8.04B
| – | – |
-1,341
| Closed | -$264K |
|
138
Consolidated Edison
ED
$35.4B
| – | – |
-2,537
| Closed | -$264K |
|
139
Ford
F
$46.8B
| – | – |
-11,630
| Closed | -$123K |
|
|
140
Medtronic
MDT
$119B
| – | – |
-3,306
| Closed | -$298K |
|
141
McCormick & Company Non-Voting
MKC
$18.9B
| – | – |
-2,540
| Closed | -$209K |
|
|
142
Novo Nordisk
NVO
$251B
| – | – |
-2,267
| Closed | -$270K |
|
143
Organon & Co
OGN
$2.45B
| – | – |
-10,760
| Closed | -$206K |
|
144
Pfizer
PFE
$141B
| – | – |
-8,858
| Closed | -$256K |
|
145
Rio Tinto
RIO
$102B
| – | – |
-3,182
| Closed | -$226K |
|